Skip to content

Epidermolysis Bullosa Simplex 5b With Muscular Dystrophy C2931072

Published: July 22, 2026Updated: August 20, 2026

A rare genetic skin condition associated with progressive muscle weakness. Skin blistering occurs along with muscular dystrophy symptoms. Multidisciplinary care addressing both skin and muscle involvement is needed.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q84.9
ICD-11
LA00.0
Body system
dermatologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(dermatologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Meticulous skin protection protocol

Implement comprehensive skin protection strategies including padded clothing, protective footwear, and avoiding activities that cause friction or trauma to the skin.

lifestyle
3

Antibiotic therapy for infected wounds

Systemic antibiotics prescribed when bacterial infection is confirmed or suspected in blistered areas. Culture-directed therapy helps target specific pathogens effectively.

medication

Additional treatment options

Physical therapy for muscular dystrophy component

Physical therapy focused on maintaining joint mobility, preventing contractures, and preserving muscle function. Stretching and range-of-motion exercises are essential components.

physical_therapy

Cardiac and respiratory monitoring

Regular monitoring of cardiac and respiratory function given the muscular dystrophy component. Pulmonary function tests and echocardiograms at regular intervals.

monitoring

Silicone gel sheeting for scarring

Application of medical-grade silicone gel sheets to established scars to improve appearance, reduce itching, and soften scar tissue over time.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Epidermolysis Bullosa Simplex 5b With Muscular Dystrophy C2931072?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Epidermolysis Bullosa Simplex 5b With Muscular Dystrophy C2931072. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy